The definition and determination of quality health care is an important topic. The purpose of this study was to develop a longitudinal method to define a quality procedure by creating a formal approach to pre- and postoperative outcomes documentation. The authors worked to define quality outcomes by first documenting the patient's condition. Goals were determined together by the surgeon and the patient and then were evaluated to see if those goals were met.
The population consisted of cancer patients with newly diagnosed metastatic brain disease who were scheduled to undergo stereotactic radiosurgery. Surgeons recorded perioperatively objective information related to preoperative goals, clinical findings, surgical performance and/or error, and whether goals were met. In addition, patients completed pre- and postprocedure questionnaires (Rand 36-Item Short-Form Health Survey 1.0 [SF-36]).
Procedural goals, defined as completing radiosurgery without error or complication and same-day discharge, were met in all patients. The clinically predetermined goal of tumor palliation was met in all but 1 patient at follow-up. The SF-36 scores remained stable except for the general health domain, which was lower (p = 0.006).
Procedural goals can be defined and objectively measured serially. The authors think that quality care can be defined as a process that achieves predefined goals without significant error and maintains or improves health.
Abbreviations used in this paper:GKS = Gamma Knife surgery; QOL = quality of life; SF-36 = Rand 36-Item Short-Form Health Survey 1.0; WBRT = whole-brain radiation therapy.
Address correspondence to: Douglas Kondziolka, M.D., Department of Neurosurgery, NYU Langone Medical Center, New York University, 530 First Avenue, New York, New York 10016. email: email@example.com.
Please include this information when citing this paper: published online February 8, 2013; DOI: 10.3171/2013.1.JNS111681.
AddeoRCaragliaMFaiolaVCapassoEVincenziBMontellaL: Concomitant treatment of brain metastasis with whole brain radiotherapy [WBRT] and temozolomide [TMZ] is active and improves quality of life. BMC Cancer7:182007
American Society of Health-System Pharmacists: ASHP therapeutic guidelines on antimicrobial prophylaxis in surgery. american society of health-system pharmacists. Am J Health Syst Pharm56:1839–18881999
BallAERussellEMSeymourDGPrimroseWRGarrattAM: Problems in using health survey questionnaires in older patients with physical disabilities. Can proxies be used to complete the SF-36?. Gerontology47:334–3402001
LinskeyMEAndrewsDWAsherALBurriSHKondziolkaDRobinsonPD: The role of stereotactic radiosurgery in the management of patients with newly diagnosed brain metastases: a systematic review and evidence-based clinical practice guideline. J Neurooncol96:45–682010
MehtaMPTsaoMNWhelanTJMorrisDEHaymanJAFlickingerJC: The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for brain metastases. Int J Radiat Oncol Biol Phys63:37–462005
MuacevicAWowraBSiefertATonnJCSteigerHJKrethFW: Microsurgery plus whole brain irradiation versus Gamma Knife surgery alone for treatment of single metastases to the brain: a randomized controlled multicentre phase III trial. J Neurooncol87:299–3072008
SamsaGEdelmanDRothmanMLWilliamsGRLipscombJMatcharD: Determining clinically important differences in health status measures: a general approach with illustration to the Health Utilities Index Mark II. Pharmacoeconomics15:141–1551999
StafinskiTJhangriGSYanEMenonD: Effectiveness of stereotactic radiosurgery alone or in combination with whole brain radiotherapy compared to conventional surgery and/or whole brain radiotherapy for the treatment of one or more brain metastases: a systematic review and meta-analysis. Cancer Treat Rev32:203–2132006